Loading…
Based on limited metadata, the FDA issued a Warning Letter to Cadila Healthcare Limited, a pharmaceutical company, on October 29, 2019, regarding drug products. Without access to the full letter text or detailed subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug regulation authority, though the specific issuing office is not identified in the metadata provided.